These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock. Silomon M, Pizanis A, Larsen R, Rose S. J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229 [Abstract] [Full Text] [Related]
17. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Dhainaut JF, Tenaillon A, Le Tulzo Y, Schlemmer B, Solet JP, Wolff M, Holzapfel L, Zeni F, Dreyfuss D, Mira JP. Crit Care Med; 1994 Nov; 22(11):1720-8. PubMed ID: 7956274 [Abstract] [Full Text] [Related]
18. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction]. Sagach VF, Dmitrieva AV. Fiziol Zh (1978); 1990 Nov; 36(4):8-14. PubMed ID: 2172032 [Abstract] [Full Text] [Related]
19. Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury. Xiao J, Zhao D, Hou T, Wu K, Zeng H. Chin Med J (Engl); 1998 May; 111(5):443-6. PubMed ID: 10374355 [Abstract] [Full Text] [Related]